http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110032608-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9373be4e32e6dcaaad553440ff1b40da
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
filingDate 2009-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab8f05759a3cc830aded61040aececdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8a8b1fde452d57d1fc64d78a5194959
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_965555bea0458dc21223f15fe1b12e1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a9b8949b816596f9139f59e3864acf7
publicationDate 2011-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20110032608-A
titleOfInvention Pharmaceutical Compositions of Tablets Containing Lassidipine
abstract The present invention relates to lacidipine tablets, by forming a coprecipitation compound of lacidipine and polyvinylpyrrolidone to formulate lacidipine into tablets to increase the dissolution rate of lacidipine, a poorly water-soluble drug.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112168798-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2705839-A1
priorityDate 2009-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID220674
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449618333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836

Total number of triples: 49.